Concepedia

Anna Akrami

AA

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2008

Affiliations

Amgen (United States)(Current)

Anna Akrami is an author at Amgen (United States) specializing in pharmacology, pharmacy, and bioavailability.

Publications per year

2008–2022

6

Publications

6

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans

Narender R. Gavva, James Treanor, András Garami et al. · Pain · 2008 · 518 citations

, , +14

The Co‐Crystal Approach to Improve the Exposure of a Water‐Insoluble Compound: AMG 517 Sorbic Acid Co‐Crystal Characterization and Pharmacokinetics

Annette Bak, Anu Gore, Evelyn Yanez et al. · Journal of Pharmaceutical Sciences · 2008 · 218 citations

, , +11

Characterization and Optimization of AMG 517 Supersaturatable Self‐Emulsifying Drug Delivery System (S‐SEDDS) for Improved Oral Absorption

Ping Gao, Anna Akrami, Francisco J. Álvarez et al. · Journal of Pharmaceutical Sciences · 2008 · 165 citations

, , +16

Enhanced Bioavailability of a Poorly Soluble VR1 Antagonist Using an Amorphous Solid Dispersion Approach: A Case Study

Michael Kennedy, Jack Hu, Ping Gao et al. · Molecular Pharmaceutics · 2008 · 149 citations

, , +17

Population Pharmacokinetic/Pharmacodynamic Model of Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Activity After Oral Administration of AMG 221, a Selective 11β-HSD1 Inhibitor

John P. Gibbs, Maurice G. Emery, Ian McCaffery et al. · The Journal of Clinical Pharmacology · 2010 · 40 citations

, , +15

1–5 of 6